Introduction Semaglutide, A medication that has taken the healthcare world by storm, is revolutionizing the treatment landscape for individuals with type 2 diabetes and obesity. Initially developed as a treatment for diabetes, Semaglutide belongs to the GLP-1 (glucagon-like peptide-1) receptor agonist class of drugs. By mimicking the natural hormone GLP-1, https://franciscodwndr.ttblogs.com/11111135/semaglutide-a-game-changing-medication-transforming-health-management